Originally Posted by
MAC
Imagine all those analyst today, sitting in their high rise office buildings, drinking their cappachino’s trying to knock up PEB revenue projections and valuations. I just wonder too how many of the international biotech indices and associated stock watchers will do the same thing.
And it’s not a straight forward one is it, Pacific Edge have not really disclosed a lot into the market place have they, esp in regard to all the prospective pipeline product revenues and profitability.
Brent Pownell’s inbox must be totally bursting with information requests, tempted to send him a couple myself.
It can only add to liquidity, and quality liquidity too, not the can’t be bothered with research just follow squiggly lines set.
Onward and upward.